Science Explorer Back to mapMap
Discussion
Researcher · Medivir (Sweden) · Sweden

Paul Targett‐Adams

Paul Targett‐Adams publishes mostly in Hepatology, Epidemiology and Molecular Biology, on topics such as Hepatitis C virus research, Hepatitis B Virus Studies and Liver Disease Diagnosis and Treatment.

ORCID 0000-0003-4967-1668 OpenAlex
World rank
#750,255
of 7,710,434 ranked researchers
Rank in Sweden
#9,396
of 71,437
Works
47
Citations
3k
Citations per work
64.9
h-index
24
i10-index 33Top 21% in Hepatology
Paul Targett‐Adams

What does Paul Targett‐Adams research?

Paul Targett‐Adams's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (5%).

Health Sciences: 26 works · 55.4% of their workMedicine: 26 works · 55.4% of their workEpidemiology: 11 works · 24.1% of their workHepatology: 11 works · 24.1% of their workHematology: 2 works · 3.6% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 3.6% of their workEverything else: 11 works · 22.7% of their workLife Sciences: 10 works · 21.9% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 16.8% of their workMolecular Biology: 8 works · 16.8% of their workImmunology and Microbiology: 2 works · 5.1% of their workImmunology: 2 works · 5.1% of their workTHEIR WORKPaulTargett‐Adams47works
Life Sciences22%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2655.4%
  2. Everything else1122.7%
    1. Biochemistry, Genetics and Molecular Biology816.8%
    2. Immunology and Microbiology25.1%
  1. 1Hepatology24% of their works
  2. 2Epidemiology24% of their works
  3. 3Molecular Biology17% of their works
  4. 4Immunology5% of their works
  5. 5Hematology4% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Paul Targett‐Adams's research?

The keywords of their largest research topics: Antiviral Therapy, Liver Disease, Hepatitis C Virus, Treatment, Hepatocellular Carcinoma, Chronic Hepatitis B, Hepatitis B Virus and NAFLD.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Antiviral Therapy492 topics
  2. Liver Disease492 topics
  3. Hepatitis C Virus331 topic
  4. Treatment331 topic
  5. Hepatocellular Carcinoma282 topics
  6. Chronic Hepatitis B161 topic
  7. Hepatitis B Virus161 topic
  8. NAFLD121 topic
  9. NASH121 topic
  10. AML51 topic
  11. Acute Myeloid Leukemia51 topic
  12. Antiretroviral Therapy51 topic
  13. Fc Receptors51 topic
  14. HIV Infection51 topic
  15. Therapeutic Antibodies51 topic
  16. Calcineurin31 topic
  17. Endoplasmic Reticulum31 topic
  18. NFAT31 topic
  19. Stress31 topic

Where does Paul Targett‐Adams work?

Paul Targett‐Adams's main affiliation in the publication record is Medivir (Sweden), Sweden.

How many publications and citations does Paul Targett‐Adams have?

OpenAlex counts 47 works and 3,050 citations for Paul Targett‐Adams, an h-index of 24, ranking #750,255 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Paul Targett‐Adams. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.